Provided by Tiger Trade Technology Pte. Ltd.

DexCom

87.96
+1.511.75%
Volume:1.17M
Turnover:102.87M
Market Cap:33.19B
PE:34.68
High:88.79
Open:86.05
Low:86.05
Close:86.45
52wk High:92.59
52wk Low:54.11
Shares:377.36M
Float Shares:376.00M
Volume Ratio:0.55
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.54
EPS(LYR):2.09
ROE:38.49%
ROA:10.33%
PB:12.66
PE(LYR):42.10

Loading ...

Dexcom Shares Rise 4.6% in Extended Trading After Posting Quarterly Results

THOMSON REUTERS
·
Jul 31

Dexcom Q2 Adjusted EPS USD 0.7 Vs. IBES Estimate USD 0.61

Reuters
·
Jul 31

DexCom Q2 Adj. EPS $0.70 Beats $0.61 Estimate, Sales $1.308B Beat $1.290B Estimate

Benzinga Earnings
·
Jul 31

Dexcom Outlook FY Revenue USD 5,180-5,250 Million

THOMSON REUTERS
·
Jul 31

Dexcom Q2 Adjusted Gross Profit USD 838.5 Million

THOMSON REUTERS
·
Jul 31

DexCom options imply 6.7% move in share price post-earnings

TIPRANKS
·
Jul 31

Alert from Law Firm on DexCom Withdrawn

Reuters
·
Jul 29

Did Dexcom, Inc. Insiders Breach Their Fiduciary Duties to Shareholders?

THOMSON REUTERS
·
Jul 29

DexCom Price Target Announced at $96.00/Share by UBS

Dow Jones
·
Jul 29

UBS Adjusts Price Target on DexCom to $96 From $95, Maintains Buy Rating

MT Newswires Live
·
Jul 28

DexCom resumed with a Buy at UBS

TIPRANKS
·
Jul 28

DexCom Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 28

Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (THC) and Dexcom (DXCM)

TIPRANKS
·
Jul 27

Dexcom Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 25

Earning Preview: DexCom Q2 revenue is expected to increase by 14.75%, and institutional views are bullish

Earnings Agent
·
Jul 24

Dexcom Joins FDA TEMPO Digital Health Devices Pilot Program

Reuters
·
Jul 23

Dexcom Announced as First Participant Selected for Fda's Tempo Digital Health Devices Pilot Program

THOMSON REUTERS
·
Jul 23

Dexcom Inc. Stock Falls 4.4%, Underperforms Peers

Dow Jones
·
Jul 23

Movement Alert|DexCom Falls 5.06% in Regular Trading, Trading at $70.91

Market Focus
·
Jul 23

US FDA - Selects Dexcom as First Tempo Pilot Participant for Glucose Health Program

THOMSON REUTERS
·
Jul 23